Biosimilar Newsletter Archive

31. 05.07.21 -- 4 Tips To Navigating The Biopharma Fast Lane 5/7/2021

    05/07/21 Biosimilar Development Newsletter

32. 05.06.21 -- No, Biologics Are Not Natural Monopolies 5/6/2021
    05/06/21 Biosimilar Development Newsletter
33. 05.03.21 -- Considerations For A Successful Process Development 5/3/2021

    05/03/21 Biosimilar Development Newsletter

34. 04.29.21 -- Making Sense Of Antibody Epitope Claims 4/29/2021
    04/29/21 Biosimilar Development Newsletter
35. 04.23.21 -- Make Buffer Management And Chromatography Your Competitive Advantages 4/23/2021

    04/23/21 Biosimilar Development Newsletter

36. 04.22.21 -- Interacting With FDA During Biosimilar Development 4/22/2021
    04/22/21 Biosimilar Development Newsletter
37. 04.19.21 -- Cell & Gene Therapy Process Development Resources 4/19/2021

    04/19/21 Biosimilar Development Newsletter

38. 04.15.21 -- The Biosimilar Leadership Playbook: 5 Tips For Success 4/15/2021
    04/15/21 Biosimilar Development Newsletter
39. 04.14.21 -- Accelerate Viral Detection From Weeks To Days 4/14/2021

    04/14/21 Biosimilar Development Newsletter

40. 04.11.21 -- Biosimilar Education Across Europe: The Right Message 4/11/2021
    04/11/21 Biosimilar Development Newsletter